Company

Hanmi Pharm. Co. Ltd

Headquarters: Seoul, South Korea

Employees: 2,155

CEO: Mr. Jong-Soo Woo Ph.D.

KRX: 128940 -0.93%

Market Cap

₩3.639 Trillion

KRW as of July 1, 2024

US$2.63 Billion

Market Cap History

Hanmi Pharm. Co. Ltd Categories

South Korea Healthcare Drug Manufacturers—Specialty & Generic
South Korea Healthcare South Korea Drug Manufacturers—Specialty & Generic

Hanmi Pharm. Co. Ltd market capitalization over time

Evolution of Hanmi Pharm. Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Hanmi Pharm. Co. Ltd

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector:
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Detailed Description

Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Hanmi Pharm. Co. Ltd has the following listings and related stock indices.


Stock: KRX: 128940 wb_incandescent

Details

Headquarters:

14, Wiryeseong-daero

Songpa-gu

Seoul, 05545

South Korea

Phone: 82 2 410 9114

Fax: 82 2 410 9259